GRAIL, Inc. (GRAL) stock
GRALNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$102.10−3.78 (-3.57%)
Close on Nov 18, 2026Market cap $4.56BP/E –Yield –
Grail revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Grail's revenue for the twelve months ending Jun 30, 2026 was $165.26M, up 23.1% year over year. For fiscal 2025 it was $147.17M, up 17.2% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $147.17M | +17.2% |
| FY2024 | Dec 31, 2024 | $125.60M | +34.9% |
| FY2023 | Dec 31, 2023 | $93.11M | +67.6% |
| FY2022 | Jan 1, 2023 | $55.55M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $44.69M | +25.7% |
| Q1 FY2026 | Mar 31, 2026 | $40.79M | +28.1% |
| Q4 FY2025 | Dec 31, 2025 | $43.60M | +14.0% |
| Q3 FY2025 | Sep 30, 2025 | $36.19M | +26.3% |
| Q2 FY2025 | Jun 30, 2025 | $35.54M | +11.2% |
| Q1 FY2025 | Mar 31, 2025 | $31.84M | +19.1% |
| Q4 FY2024 | Dec 31, 2024 | $38.25M | +26.1% |
| Q3 FY2024 | Sep 30, 2024 | $28.65M | +38.3% |
| Q2 FY2024 | Jun 30, 2024 | $31.97M | +42.6% |
| Q1 FY2024 | Mar 31, 2024 | $26.72M | – |
| Q4 FY2023 | Dec 31, 2023 | $30.33M | – |
| Q3 FY2023 | Oct 1, 2023 | $20.72M | – |
| Q2 FY2023 | Jun 30, 2023 | $22.41M | – |
See a number that looks wrong?